(Q33899829)

English

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

J B Dumond

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M Vourvahis

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

N L Rezk

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

K B Patterson

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

H-C Tien

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

N White

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S H Jennings

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S O Choi

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Li

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M J Wagner

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

N M La-Beck

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M Drulak

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J P Sabo

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M A Castles

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

T R Macgregor

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A D M Kashuba

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

10 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

735-742

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Interaction between lopinavir/ritonavir and warfarin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

The human intestinal cytochrome P450 "pie".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

Potential interaction involving warfarin and ritonavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

5 July 2018

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 118

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.253

21 January 2018

Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

29 October 2018

Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882206

29 October 2018

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/20147896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in caffeine metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20147896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ritonavir and warfarin interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20147896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux

1 reference

https://pubmed.ncbi.nlm.nih.gov/20147896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CLPT.2009.253

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33899829&oldid=2195956298"